Research and development of new diagnostic and therapeutic metodologies
A.A. 2019/2020
Obiettivi formativi
The aims of this course will be to provide an up-date knowledge of novel, emerging basic and technical aspects in the diagnosis and therapeutic approaches in cancer.
In particular, the course will be focused on mouse models, organoids, relevance of NGS in the context of tumor heterogeneity, the emerging role of non coding RNAs as therapeutic platforms,
the advance of minimal residual disease approaches in the management of patients in the era of new drugs, and the physical bases and possible applications of the most important imaging techniques
In particular, the course will be focused on mouse models, organoids, relevance of NGS in the context of tumor heterogeneity, the emerging role of non coding RNAs as therapeutic platforms,
the advance of minimal residual disease approaches in the management of patients in the era of new drugs, and the physical bases and possible applications of the most important imaging techniques
Risultati apprendimento attesi
In particular, by following this course it will be possible to learn about:
Animal models as diagnostic and therapeutic tools
Rationale for NGS studies in cancer
The clinical relevance of the non coding RNAs
Molecular monitoring of hematological malignancies
Imaging techniques for clinical and pre-clinical oncological studies
Animal models as diagnostic and therapeutic tools
Rationale for NGS studies in cancer
The clinical relevance of the non coding RNAs
Molecular monitoring of hematological malignancies
Imaging techniques for clinical and pre-clinical oncological studies
Periodo: Terzo trimestre
Modalità di valutazione: Esame
Giudizio di valutazione: voto verbalizzato in trentesimi
Corso singolo
Questo insegnamento non può essere seguito come corso singolo. Puoi trovare gli insegnamenti disponibili consultando il catalogo corsi singoli.
Programma e organizzazione didattica
Edizione unica
Responsabile
Periodo
Terzo trimestre
Programma
Pathology:
The pathology lab: a platform for patients' diagnosis and therapy
Technologies and methods for assessing predictive factors in cancer patients.
Molecular follow-up of tumor resistance: the liquid biopsy model.
Pathology in the multidisciplinary team: from morphology to genome.
Radiology:
Main Diagnostic Imaging procedures and their applications. RX/CT and Ultrasound: Principles and methods for ultrasound imaging; clinical and pre-clinical applications. Magnetic Resonance Imaging (MRI): methodology, and advanced applications. Nuclear based techniques: Principles and methods of single photon emission tomography (SPECT), positron emission tomography (PET) imaging procedures and main tracers for oncological imaging. Introduction to Radiomics.
Blood diseases:
Clonal heterogeneity in blood cancers by NGS Novel classifications and their biological and prognostic relevance in hematological tumors based on NGs study Use of murine models for the study of mutations affecting splicing factors in the pathogenesis of myeloid disorders. Monitoring the minimal residual disease in hematological neoplasms: technical advances and clinical implications Non coding RNA in blood cancers: from genetic associations, molecular mechanisms, and therapeutic strategies.
Molecular biology:
Patient-specific tumor models: from xenografts to organoids. Cancer reprogramming: from mechanism to tool for the dissection of tumor pathogenesis and the identification of draggable pathways Cancer-specific epigenetic dysregulation and its therapeutic application.
The pathology lab: a platform for patients' diagnosis and therapy
Technologies and methods for assessing predictive factors in cancer patients.
Molecular follow-up of tumor resistance: the liquid biopsy model.
Pathology in the multidisciplinary team: from morphology to genome.
Radiology:
Main Diagnostic Imaging procedures and their applications. RX/CT and Ultrasound: Principles and methods for ultrasound imaging; clinical and pre-clinical applications. Magnetic Resonance Imaging (MRI): methodology, and advanced applications. Nuclear based techniques: Principles and methods of single photon emission tomography (SPECT), positron emission tomography (PET) imaging procedures and main tracers for oncological imaging. Introduction to Radiomics.
Blood diseases:
Clonal heterogeneity in blood cancers by NGS Novel classifications and their biological and prognostic relevance in hematological tumors based on NGs study Use of murine models for the study of mutations affecting splicing factors in the pathogenesis of myeloid disorders. Monitoring the minimal residual disease in hematological neoplasms: technical advances and clinical implications Non coding RNA in blood cancers: from genetic associations, molecular mechanisms, and therapeutic strategies.
Molecular biology:
Patient-specific tumor models: from xenografts to organoids. Cancer reprogramming: from mechanism to tool for the dissection of tumor pathogenesis and the identification of draggable pathways Cancer-specific epigenetic dysregulation and its therapeutic application.
Prerequisiti
The student must have acquired the general concepts of the basic radiation physics, of biological and molecular pathogenetic mechanisms of human diseases and the basic laboratory techniques for the study of cellular functions, phenotype and genome.
Metodi didattici
The teachers will use frontal lessons with visual support material.
The teachers will use the Ariel platform to provide the teaching material which consists of a copy of the presentations used in the lectures and other educational material. Attendance to lectures and disciplinary laboratory activities is mandatory
The teachers will use the Ariel platform to provide the teaching material which consists of a copy of the presentations used in the lectures and other educational material. Attendance to lectures and disciplinary laboratory activities is mandatory
Materiale di riferimento
Students will receive pdf files of the presentations used during the lectures.
Moreover review articles will be available on the different topics.
Moreover review articles will be available on the different topics.
Modalità di verifica dell’apprendimento e criteri di valutazione
The exam will be a written test on the topics listed in the programme. In particular, each student will be given a test consisting of 6 open questions for the duration of one and a half hours and the mark will be expressed in thirtieths. Each student will be evaluated for the knowledge of the subject, the ability to organize the answer in a discursive way and the competence in the use of specialist vocabulary. Each student will be provided with all the tools necessary for passing the exam.
Moduli o unità didattiche
Blood diseases
MED/15 - MALATTIE DEL SANGUE - CFU: 2
Lezioni: 14 ore
Docenti:
Bolli Niccolo', Neri Antonino
Turni:
Molecular biology
BIO/11 - BIOLOGIA MOLECOLARE - CFU: 2
Lezioni: 14 ore
Docente:
Testa Giuseppe
Turni:
-
Docente:
Testa Giuseppe
Pathology
MED/08 - ANATOMIA PATOLOGICA - CFU: 1
Lezioni: 7 ore
Docente:
Pruneri Giancarlo
Turni:
-
Docente:
Pruneri Giancarlo
Radiology
MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA - CFU: 1
Lezioni: 7 ore
Docente:
Ottobrini Luisa
Turni:
-
Docente:
Ottobrini LuisaDocente/i
Ricevimento:
da concordare via email
Laboratorio di Ematologia, Padiglione Marcora secondo piano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milano
Ricevimento:
previo appuntamento da concordare via e-mail
Ricevimento:
previo appuntamento da concordare via e-mail
Ricevimento:
previo appuntamento da concordare via e-mail
Istituto Nazionale dei Tumori - Blocco F piano 1 - Via Venezian, 1 - Milano